J. Richard Whitley's most recent trade in Dogwood Therapeutics Inc. was a trade of 2,362 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 2,362 | 2,362 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 210 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 210 | 420 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | J. Richard Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 4,000 | 4,000 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 08 Dec 2022 | 1,800 | 700 | - | 0.3 | 466 | Common Stock |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 5,250 | 5,250 | - | - | Stock Option (right to buy) | |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 4.53 per share. | 18 May 2022 | 500 | 2,500 | - | 4.5 | 2,263 | Common Stock |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 06 Jan 2022 | 1,800 | 2,000 | - | 5.7 | 10,296 | Common Stock |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Purchase of securities on an exchange or from another person at price $ 5.72 per share. | 23 Dec 2021 | 200 | 200 | - | 5.7 | 1,145 | Common Stock |
| Dogwood Therapeutics Inc. | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 7,875 | 7,875 | - | - | Stock Option (right to buy) | |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 1,936 | 33,058 (0%) | 0% | - | Common Stock | |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2021 | 1,936 | 4,028 | - | - | Restricted Stock Unit | |
| Gilead Sciences | Richard J. Whitley | Director | Sale of securities on an exchange or to another person at price $ 64.57 per share. | 03 May 2021 | 20,282 | 31,122 (0%) | 0% | 64.6 | 1,309,655 | Common Stock |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.65 per share. | 03 May 2021 | 20,282 | 51,404 (0%) | 0% | 20.6 | 418,722 | Common Stock |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 20,282 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 62 | 5,871 | - | - | Phantom Stock | |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 1,434 | 5,739 | - | - | Phantom Stock | |
| Gilead Sciences | Richard J. Whitley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 1,434 | 31,122 (0%) | 0% | 0 | Common Stock | |
| Gilead Sciences | Richard J. Whitley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 77 | 7,174 | - | - | Phantom Stock |